Duty D12-59T, published by Directorate General of Health Services, Ministry of Health and Family Welfare [D12-59T]
As at 7 September 2026. In force from 18 April 2021.
Addressee: Every manufacturer.
Required: Obtain a licence before undertaking the manufacture of drugs; apply in Form 25, fee five hundred rupees.
Period: Before the activity begins; licence valid three years.
Form: Form 25.
Source: Section 6, Surrogacy (Regulation) Act, 2021 [S2A-7ZA].
Penalty provision: Section 45, Surrogacy (Regulation) Act, 2021 [S2A-960].
Published by: Directorate General of Health Services, Ministry of Health and Family Welfare.
In force: from 18 April 2021.